It is called the seed coat
Hello. This question is incomplete. Also, you forgot to show the flowchart. The flowchart is attached below and the full question is:
The flowchart below shows the three generations of a cross between a pea plant that has yellow pods and a pea plant that has green pods. Green pods are the dominant trait. The flowchart is missing the labels that describe the traits.
In which squares should the phrase “Green pods” appear?
1.A and D 2.B and E 3.A,C and D 4.A,B,C,D and E
Answer:
3.A,C and D
Explanation:
As shown in the question above, the flowchart shows the crossing of a pea plant with dominant features (green pods - AA) and a pea plant with recessive features (yellow features - aa). The crossing between plants with AA and aa alleles generates a completely Aa population, which in this case, has the dominant characteristic, that is, it has green pods. This is because the "Aa" alleles are called heterozygous and develop the dominant characteristic.
As we can see in the flowchart, the crossing between the two pea plants generated an offspring that is identified by table C, as we know this offspring has green pods and in the flowchart it is represented by a grayish rectangle. Therefore, we can say that the other gray rectangles represent pea plants with green pods, which are rectangles A, C and D.
Human monoclonal antibody (mAbs) are emerging in the field of cancer therapy and have become an increasing proportion of new drugs that are recently approved. Although there are some methods to obtain antigen-specific mAbs from human B cells, it is generally impossible to directly immunize human beings with antigens of interest. For example, for infectious agents, those approaches are largely restricted. To solve these obstacles, two main approaches have been developed; either by humanizing antigen-specific antibodies from small experimental animals (which is laborious due to the great genetic differences from humans) or rely on the in vitro selection of antigen-specific binders from human antibody repertoires. However, the human mAbs developed by these methods are usually with low affinity.
We are now coming up with a much better idea that is humanizing non-human primates mAbs instead of murine mAbs. Due to the close genetic relationship with humans, immunized NHPs have more potential to be isolated with high affinity antibody to human target than other experimental species, such as mouse, rat and rabbit. In addition, with appropriate method, NHP antibodies are much<span> easier to be humanized</span> without any loss of affinity compared to widely used murine antibodies.
Resource: http://www.creative-biolabs.com/High-Affi-TM-Human-Antibody-Discovery.html